Bionano Genomics Inc
Change company Symbol lookup
Select an option...
BNGO Bionano Genomics Inc
$ICEFSTS ICE FactSet Taiwan Core Semiconducto
UGRO Urban-Gro Inc
NVVEW Nuvve Holding Equity Warrants Exp 19 March 2026 *W EXP 03/19/2026
AGNCN AGNC Investment Corp
XJMMX Nuveen Multi-Market Income Fund Inc
THDDY TV Asahi Holdings Corp
ABCB Ameris Bancorp
NSAUF MegumaGold Corp
TSIBW Tishman Speyer Innovation Equity II Warrant Exp 11 Feb 2026 *W EXP 02/11/2026
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. It also provides diagnostic testing services for pediatric patients suspected of neurodevelopmental disabilities. Its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to search for diagnostics and therapeutic targets and to streamline the identification of structural changes in chromosomes. The Saphyr system is consists of an instrument, chip consumables, reagents, and a suite of data analysis tools. It also provides proprietary molecular genetic diagnostic services for individuals demonstrating clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development.

Closing Price
$2.08
Day's Change
-0.07 (-3.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.09
Day's Low
1.81
Volume
(Heavy Day)
Volume:
16,604,052

10-day average volume:
9,438,434
16,604,052

Company Profile

Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. It also provides diagnostic testing services for pediatric patients suspected of neurodevelopmental disabilities. Its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to search for diagnostics and therapeutic targets and to streamline the identification of structural changes in chromosomes. The Saphyr system is consists of an instrument, chip consumables, reagents, and a suite of data analysis tools. It also provides proprietary molecular genetic diagnostic services for individuals demonstrating clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
39.68x
Price/Book (MRQ)
1.77x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

December 2021
Current Month
40.5M
Previous Month
41.5M
Percent of Float
14.32%
Days to Cover
5.0223 Days

Share Information

BNGO is in a share class of common stock
Float
282.9M
Shares Outstanding
289.2M
Institutions Holding Shares
194
24.97%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • David L. Barker
  • R. Erik HolmlinPres.
  • Christopher P StewartCFO
  • Mark OldakowskiCOO
  • Alka ChaubeyOther

Address

Insider Trading

During the most recent quarter, 5K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.